In the current ongoing pandemic situation; remote operations have become a necessity for business continuity. Document approval is obligatory to grant any authorization for many of pharmaceutical GxP business operations.
There are certain repetitive challenges, errors, and risks noticed by regulators in current document signing practices & Electronically approved document management methods. Such issues are repercussions of wrong solution selection or incorrect system configurations or erroneous operational practices.
Hence there is acute demand to understand electronic approval & signature compliance requirements to elect appropriate signature solutions & processes for implementation to achieve remote document approval counting security and compliance of sensitive GxP document.
This is precisely why CONVALgroup is leading this webinar for life science industry based on MHRA Guidance document (April 20202)so while operating remotely; industry would consistently compliant with regulations for document control & data security.
Key Take away from this session
•What are the regulatory requirements for remote approval & e signature?
•What are alternative methods to approve documents while working remotely?
•What are common electronic approval mistakes & How can we avoid those?
•Brief Work instruction for wet ink document remote approval in an emergency.
•How can I be prepared for a compliant electronic approval?